CSPC Pharmaceutical Group Statistics
Total Valuation
CSPCY has a market cap or net worth of 14.77 billion. The enterprise value is 13.70 billion.
Market Cap | 14.77B |
Enterprise Value | 13.70B |
Important Dates
The last earnings date was Wednesday, August 20, 2025.
Earnings Date | Aug 20, 2025 |
Ex-Dividend Date | Jun 5, 2025 |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | -2.62% |
Shares Change (QoQ) | -0.27% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 7.86B |
Valuation Ratios
The trailing PE ratio is 27.44 and the forward PE ratio is 19.92.
PE Ratio | 27.44 |
Forward PE | 19.92 |
PS Ratio | 4.07 |
PB Ratio | 3.03 |
P/TBV Ratio | 3.49 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 25.46 |
EV / Sales | 3.75 |
EV / EBITDA | 17.95 |
EV / EBIT | 23.26 |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.24, with a Debt / Equity ratio of 0.01.
Current Ratio | 2.24 |
Quick Ratio | 1.93 |
Debt / Equity | 0.01 |
Debt / EBITDA | 0.09 |
Debt / FCF | n/a |
Interest Coverage | 97.82 |
Financial Efficiency
Return on equity (ROE) is 10.83% and return on invested capital (ROIC) is 7.34%.
Return on Equity (ROE) | 10.83% |
Return on Assets (ROA) | 5.65% |
Return on Invested Capital (ROIC) | 7.34% |
Return on Capital Employed (ROCE) | 11.82% |
Revenue Per Employee | 188,370 |
Profits Per Employee | 27,935 |
Employee Count | 21,400 |
Asset Turnover | 0.55 |
Inventory Turnover | 2.65 |
Taxes
In the past 12 months, CSPCY has paid 144.32 million in taxes.
Income Tax | 144.32M |
Effective Tax Rate | 21.12% |
Stock Price Statistics
The stock price has increased by +99.50% in the last 52 weeks. The beta is 0.71, so CSPCY's price volatility has been lower than the market average.
Beta (5Y) | 0.71 |
52-Week Price Change | +99.50% |
50-Day Moving Average | 4.64 |
200-Day Moving Average | 3.20 |
Relative Strength Index (RSI) | 44.51 |
Average Volume (20 Days) | 3,119 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CSPCY had revenue of 3.63 billion and earned 538.19 million in profits. Earnings per share was 0.05.
Revenue | 3.63B |
Gross Profit | 2.42B |
Operating Income | 591.94M |
Pretax Income | 683.33M |
Net Income | 538.19M |
EBITDA | 742.36M |
EBIT | 591.94M |
Earnings Per Share (EPS) | 0.05 |
Balance Sheet
The company has 1.35 billion in cash and 69.10 million in debt, giving a net cash position of 1.29 billion.
Cash & Cash Equivalents | 1.35B |
Total Debt | 69.10M |
Net Cash | 1.29B |
Net Cash Per Share | n/a |
Equity (Book Value) | 4.87B |
Book Value Per Share | 0.41 |
Working Capital | 1.74B |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 66.75%, with operating and profit margins of 16.31% and 14.83%.
Gross Margin | 66.75% |
Operating Margin | 16.31% |
Pretax Margin | 18.83% |
Profit Margin | 14.83% |
EBITDA Margin | 20.46% |
EBIT Margin | 16.31% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.11, which amounts to a dividend yield of 2.00%.
Dividend Per Share | 0.11 |
Dividend Yield | 2.00% |
Dividend Growth (YoY) | -6.98% |
Years of Dividend Growth | 6 |
Payout Ratio | n/a |
Buyback Yield | 2.62% |
Shareholder Yield | 4.62% |
Earnings Yield | 3.64% |
FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
The last stock split was on November 16, 2020. It was a forward split with a ratio of 1.6.
Last Split Date | Nov 16, 2020 |
Split Type | Forward |
Split Ratio | 1.6 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |